5-methoxytryptamine has been researched along with Thrombopenia in 2 studies
5-Methoxytryptamine: Serotonin derivative proposed as potentiator for hypnotics and sedatives.
5-methoxytryptamine : A member of the class of tryptamines that is the methyl ether derivative of serotonin.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Aging and advanced cancer are characterized by similar neuroendocrine and immune deficiencies; the most important of them consist of diminished nocturnal production of the pineal hormone melatonin (MLT) and decreased production of IL-2." | 9.16 | Cancer as the main aging factor for humans: the fundamental role of 5-methoxy-tryptamine in reversal of cancer-induced aging processes in metabolic and immune reactions by non-melatonin pineal hormones. ( Lissoni, P; Messina, G; Rovelli, F, 2012) |
| " In particular, thrombopoiesis has been proven to be stimulated by melatonin, and the pineal indole has been shown to be effective in the treatment of thrombocytopenia resulting from different causes." | 9.09 | Thrombopoietic properties of 5-methoxytryptamine plus melatonin versus melatonin alone in the treatment of cancer-related thrombocytopenia. ( Bonfanti, A; Bucovec, R; Fumagalli, L; Giani, L; Lissoni, P; Mandelli, A; Roselli, MG; Rovelli, F, 2001) |
| "Aging and advanced cancer are characterized by similar neuroendocrine and immune deficiencies; the most important of them consist of diminished nocturnal production of the pineal hormone melatonin (MLT) and decreased production of IL-2." | 5.16 | Cancer as the main aging factor for humans: the fundamental role of 5-methoxy-tryptamine in reversal of cancer-induced aging processes in metabolic and immune reactions by non-melatonin pineal hormones. ( Lissoni, P; Messina, G; Rovelli, F, 2012) |
| " In particular, thrombopoiesis has been proven to be stimulated by melatonin, and the pineal indole has been shown to be effective in the treatment of thrombocytopenia resulting from different causes." | 5.09 | Thrombopoietic properties of 5-methoxytryptamine plus melatonin versus melatonin alone in the treatment of cancer-related thrombocytopenia. ( Bonfanti, A; Bucovec, R; Fumagalli, L; Giani, L; Lissoni, P; Mandelli, A; Roselli, MG; Rovelli, F, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lissoni, P | 2 |
| Messina, G | 1 |
| Rovelli, F | 2 |
| Bucovec, R | 1 |
| Bonfanti, A | 1 |
| Giani, L | 1 |
| Mandelli, A | 1 |
| Roselli, MG | 1 |
| Fumagalli, L | 1 |
2 trials available for 5-methoxytryptamine and Thrombopenia
| Article | Year |
|---|---|
Cancer as the main aging factor for humans: the fundamental role of 5-methoxy-tryptamine in reversal of cancer-induced aging processes in metabolic and immune reactions by non-melatonin pineal hormones.
Topics: 5-Methoxytryptamine; Administration, Oral; Age Factors; Aging; Antineoplastic Combined Chemotherapy | 2012 |
Thrombopoietic properties of 5-methoxytryptamine plus melatonin versus melatonin alone in the treatment of cancer-related thrombocytopenia.
Topics: 5-Methoxytryptamine; Adult; Aged; Blood Platelets; Drug Therapy, Combination; Female; Hematopoiesis; | 2001 |